Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Moodys
Cantor Fitzgerald
Express Scripts
AstraZeneca
Julphar
Colorcon
Cerilliant
UBS
Dow

Generated: August 17, 2017

DrugPatentWatch Database Preview

Flutamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for flutamide and what is the scope of flutamide freedom to operate?

Flutamide
is the generic ingredient in two branded drugs marketed by Sandoz, Actavis Labs Fl Inc, Mylan, Schering, Cipla Ltd, and Par Pharm, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for flutamide. Five suppliers are listed for this compound.

Summary for Generic Name: flutamide

Tradenames:2
Patents:0
Applicants:6
NDAs:6
Drug Master File Entries: see list11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list70
Clinical Trials: see list58
Patent Applications: see list6,800
Therapeutic Class:Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:flutamide at DailyMed

Pharmacology for Ingredient: flutamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
FLUTAMIDE
flutamide
CAPSULE;ORAL075298-001Sep 18, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
FLUTAMIDE
flutamide
CAPSULE;ORAL075818-001Sep 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
FLUTAMIDE
flutamide
CAPSULE;ORAL076224-001May 9, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FLUTAMIDE
flutamide
CAPSULE;ORAL075820-001Sep 18, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: flutamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
Schering
EULEXIN
flutamide
CAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
US Department of Justice
Colorcon
Harvard Business School
Covington
Merck
Argus Health
Daiichi Sankyo
Cipla
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot